Clarence Biotech Company Announces Cannabis Research Program
22nd Century Group Inc, a plant biotechnology company that specializes in low nicotine tobacco has announced that its subsidiary, Botanical Genetics, LLC is expanding its cannabis research program. The program will focus on the development of proprietary strains of cannabis with medical and commercial applications.
The company’s technology uses genetic engineering and breeding to alter the level of select compounds in plants. For example, the amount of nicotine in tobacco or the amount of cannabinoids in cannabis.